In March, GE Healthcare opened an Innovation Village in Cardiff, Wales, which will support 8–10 businesses.
Quantum Analytics named Marty Kaloostian as president and CEO in March. Most recently, he led Merger & Acquisition and Technology Licensing deals for Agilent Technologies.
Under an April strategic relationship, Becton, Dickinson will provide additional grant funding of up to $25,000 and professional expertise to qualifying Breakout Labs companies. Breakout Labs is a revolving fund of early-stage life science and technology companies. Breakout firm CytoVale, which is commercializing label-free cell handling and analysis, received a grant.
Thermo Fisher Scientific announced in April that during the first quarter, it acquired two channel partners covering Singapore and Malaysia, and South Korea. The partners joined the Analytical Instruments segment and were purchased for $11 million. On its first quarter conference call, Thermo announced that it opened new sales offices in Vietnam, Thailand and Indonesia.
Thermo Fisher Scientific announced that Lars Sørensen will resign from its Board in July.
In April, Thermo Fisher Scientific opened a 7,000 ft2 Customer Experience Center in Dubai located at DuBiotech.
Lab equipment and medical instrument supplier Myco-Instrumentation announced the formation of the Myco-Analytical division for used analytical instruments, with a primary focus on HPLC, LC/MS, GC/MS and atomic absorption spectroscopy.
Agilent Technologies entered into a strategic collaboration with the National University of Singapore Yong Loo Lin School of Medicine to develop more effective medicine to treat cardiovascular disease. Agilent systems will be used in a study of clinical bioanalytics.
BioMérieux first quarter Industrial Applications sales grew 14.1%, 5.6% in constant currency, to €72.3 million ($81.2 million), or 18% of revenues.
Roper Industries changed its name to Roper Technologies in April.
John Warren retired from Spectris’s Board in April.
Analytik Jena announced that orders for the first quarter fiscal 2015 ending March 31 rose 26.4% to €32.1 million ($36.1 million). Operating profit totaled €0.7 million ($0.8 million), compared to a loss of €1.5 million ($1.7 million). The company expects fiscal 2015 instrument sales to total €110 million ($124 million) and to post a fiscal 2015 operating profit of €4.0–€5.0 million ($4.5–$5.6 million).
In April, Amazon launched Amazon Business, an online B2B marketplace whose offerings include lab equipment.
First quarter revenue for Xylem’s Test business declined 3% due to a difficult year-over-year comparison.
In April, Harvard Bioscience named James Green, president and CEO of Analogic, to its Board.